Bratha

Part 4.2 — Choosing Your Ancillaries

18 min read

This is Part 4.2 of 5 in the Performance Enhancement Series — the "Tier 3" continuation of the Fitness Series' Pharmacology chapter. The full path:

Table of Contents

Framing

This article compares medications within a drug class so you can pick the member that fits you, and lists the dose ranges and cadences used in harm-reduction practice (largely following Vigorous Steve).[^1] It is education, not medical advice or a prescription. Almost every agent here is a prescription medication with real risks, contraindications, and interactions — the doses are illustrative reference points, not instructions. Choosing and dosing them is a job for a physician working from your bloodwork. This is general information for readers, not a personal protocol.

The class does the job; the member decides the fit

Part 4.0 introduced the families of protective drugs (“super ancillaries”). Part 4.1 told you when to deploy one (a marker drifts). This article is the missing middle: which member of the family to pick.

Here’s the principle that runs through everything below: ==within a class, every member does the same core job — the differences are in side-effect profile, half-life, tissue selectivity, drug interactions, and what else the molecule happens to do.== A statin lowers LDL whether it’s rosuvastatin or simvastatin; the question is which one wrecks your training with muscle aches and which one doesn’t. An ARB lowers blood pressure whether it’s telmisartan or irbesartan; the question is which secondary benefits you actually need. Picking well means matching the member’s quirks to your stack, your goals, and what’s already handled elsewhere.

Scope: this is the protective toolbox

Part 4.2 covers the ancillaries that defend health — lipids, BP, glucose, organs, hormones, hair. The performance and aesthetic compounds (fat-burners like clenbuterol and cardarine, aggressive contest diuretics, thyroid for cutting) belong to Part 4.3 — the bodybuilding realm. T4 and indapamide appear here in their protective roles; their aggressive cutting use is a Part 4.3 topic.

The stack as one ecosystem

Before picking individual members, see the whole map. This is the through-line of the series in one frame: ==a compound’s family (3.1) predicts what it does → its pathway/mechanism (3.0) determines what it loads → the load shows up as a biomarker (2.0/4.1) → which tells you the ancillary that defends it (4.0).== Read the table that way — left to right is the whole logic of enhanced harm reduction.

Compound (family)What it loads (mechanism)Watch (biomarker)Matching ancillary
Testosterone (T)Aromatization → E2 & water; →DHT → hair; HPTA shutdownE2, BP, hairline, LH/FSHInjection frequency (± minimal AI); finasteride/topical; HCG/HMG
Boldenone / EQ (T)↑EPO + ↓hepcidin → hematocrit; hyper-viscous blood → renal shearHematocrit/Hgb, cystatin C/eGFRPhlebotomy + aspirin (± nattokinase); ARB
Trenbolone (19-nor)Progesterone → prolactin; strongly atherogenic; neuroProlactin, HDL/ApoB, mood/sleepP5P (→ cabergoline); statin + ezetimibe; sleep/neuro stack
Nandrolone (19-nor)Progesterone → prolactin; mild estrogenProlactin, estroneP5P; HCG (intratesticular support)
Anavar / orals (DHT, 17-aa)Hepatic lipase → HDL crush; bile/liver strainHDL/ApoB, GGT/ALT/ASTRosuvastatin + ezetimibe (+ citrus bergamot); TUDCA + NAC
GH / secretagogues / insulinInsulin resistance; extracellular water; burns through T4Fasting glucose/HbA1c, BP, free T4Metformin/berberine; ARB; T4 (only with GH)
Whole stack (RAAS)Sodium/water → BP; LVH (pressure + direct cardiac-AR)BP, echo/ECGARB (± tadalafil, nebivolol); limit dose/duration

In a stack, risks multiply — so defend by system, not by drug

The loads overlap: Test, EQ, and GH all push BP and water at once; EQ and the orals hit different organs but stack on the same cardiovascular picture. ==You don’t run “one ancillary per compound” — you protect each system (cardiovascular, renal, hepatic, metabolic, endocrine) against the combined load,== which is why the same ARB or statin covers several compounds at once. The rest of this article is how you pick the best member for each of those system defenses.

Statins (cholesterol) — hydrophilic vs. lipophilic

Family job: lipid management — lowering LDL/ApoB to defend your arteries. The single most useful split in the entire ancillary world, because it determines whether the drug aches your muscles. The job (block hepatic cholesterol synthesis, lower LDL/ApoB — see Part 4.0) is shared; water-solubility decides the side-effect profile.[^2]

Clearing up a common myth

==Rosuvastatin is hydrophilic (water-soluble), not fat-soluble — and that is exactly why it’s gentler on muscle.== Hydrophilic statins (rosuvastatin, pravastatin) rely on an active liver transporter (OATP1B1) to get into hepatocytes and barely diffuse into peripheral muscle, so they cause less myalgia. Lipophilic (fat-soluble) statins (simvastatin, atorvastatin, lovastatin, fluvastatin, pitavastatin) passively diffuse into many tissues including muscle, which is why they cause more muscle aches — simvastatin at 80 mg being the classic offender. If you’ve heard “rosuvastatin is fat-soluble,” that’s backwards.

Hydrophilic (water-soluble)Lipophilic (fat-soluble)
MembersRosuvastatin, pravastatinSimvastatin, atorvastatin, lovastatin, fluvastatin, pitavastatin
Muscle aches (myalgia)Lower — liver-selective, minimal muscle diffusionHigher — diffuse into muscle
Potency (LDL ↓)Rosuvastatin = most potent statinAtorvastatin potent; simvastatin moderate
Drug interactionsMinimal (rosuvastatin barely CYP-metabolised)Higher — simva/atorva/lova use CYP3A4 (interaction-prone in a deep stack)
Half-lifeRosuvastatin ~19 h (dose anytime)Mostly shorter (dose at night)

How to choose. For a hard-training enhanced athlete, muscle aches that blunt your sessions are a real cost — so the hydrophilic statins win. Rosuvastatin is the default: most potent, water-soluble, few interactions, long half-life. Pravastatin is the gentlest if even rosuvastatin nags. ==And the smartest move is to keep the statin dose low by pairing it with ezetimibe== (a gut cholesterol-absorption inhibitor — it closes the other door, blocking dietary/biliary cholesterol uptake) — two mechanisms, less of either, fewer side effects.

ARBs (blood pressure) — which “sartan”?

Family job: blood-pressure control + kidney and heart protection. All angiotensin-receptor blockers lower blood pressure and protect the kidneys and heart from androgen-driven strain. The members differ in lipophilicity, half-life, and bonus effects.[^3]

  • Telmisartan — the most lipophilic ARB, so it penetrates deep into vascular wall and heart muscle, giving it the strongest record for reversing left ventricular hypertrophy. Longest half-life (~24 h) → flat, forgiving 24-hour coverage that won’t spike if you dose a few hours late. It’s also a partial PPAR-γ agonist (a metabolic bonus).
  • Irbesartan — a powerful BP-lowerer with strong renal protection (it shields the kidney’s filtering units), but a shorter half-life (~11–15 h), so coverage can thin out by hours 18–24 (possible early-morning creep). Minimal PPAR-γ.
  • Valsartan — the balanced, widely-used middle option. Losartan — the weakest ARB, but uniquely uricosuric (it lowers uric acid), useful if gout/high uric acid is also in the picture. Candesartan / olmesartan — potent and long-acting.

The PPAR-γ reality check

Telmisartan’s PPAR-γ activation is overhyped in fitness circles. At a “baby dose” of 20–40 mg it’s mild; you need the full 80 mg to get drug-like metabolic effects most people don’t need just for BP. And ==if your metabolic management is handled elsewhere — a GIP agent like retatrutide, semaglutide, or tirzepatide — those dwarf anything an ARB’s PPAR-γ could do, making the telmisartan “metabolic edge” redundant.==[^1]

How to choose. Want the LVH-reversal, 24-hour-flat, mild-metabolic edge and you’re not getting metabolic effects from a GLP-1? Telmisartan. Want a clean, fiercely kidney-protective BP anchor and your metabolism is handled by diet/GLP-1? Irbesartan or valsartan. Also fighting high uric acid? Losartan. And note: if you’re already running rosuvastatin (endothelium/lipids), aspirin (clotting), and tadalafil (nitric-oxide vasodilation), telmisartan’s tissue-penetration advantage drops from “lifeline” to “nice-to-have” — irbesartan + tadalafil is already a rock-solid pairing (two BP mechanisms, smooth 24-hour control).

Aldosterone blockers (MRAs) — fluid and cardiac protection

Family job: blocking aldosterone to control fluid/blood pressure and protect against cardiac fibrosis — the advanced “longevity” tier. On cycle, androgens + heavy carbs chronically upregulate the RAAS, raising aldosterone — which holds sodium, expands blood volume, and (the real long-term danger) drives cardiac fibrosis and kidney damage. Mineralocorticoid-receptor antagonists block aldosterone at the receptor, downstream of where ARBs act.[^4]

  • Spironolactone — ==avoid in bodybuilding.== It’s non-selective and blocks androgen receptors, causing gynecomastia and anti-androgen effects — it actively sabotages your cycle.
  • Eplerenone — selective MRA: no anti-androgen/gyno effect, blocks aldosterone at heart/vessel/kidney, fixes water retention at the cellular level and shields against cardiac remodeling. ~25–50 mg/day. The bodybuilder’s MRA.
  • Finerenone — newer, non-steroidal, distributes evenly between heart and kidney (older MRAs concentrate in the kidney), with a lower hyperkalemia risk — but cutting-edge and expensive.

How to choose. This is an advanced longevity layer most people won’t need on top of an ARB + diuretic. If you do: eplerenone (selective, no gyno) is the practical pick; finerenone if you want the newest cardio-renal protection and budget isn’t a constraint. ==Do not stack an MRA + ARB + thiazide all at once== without close supervision — the combined potassium and dehydration risk is serious.

Blood-pressure adjuncts — tadalafil, nebivolol, indapamide

Different mechanisms you layer with an ARB for two-/three-angle control:

  • Tadalafil (PDE5 inhibitor) — raises nitric oxide → vasodilation, attacking BP from a different angle than the ARB. Long half-life (~17.5 h) → smooth, steady control (no spikes mid-squat), at a daily 5 mg. Bonus: pumps, prostate relief, mild diuresis (Part 4.0’s “super ancillary” champion).
  • Nebivolol — a β1-selective beta-blocker that also raises nitric oxide. It’s the heart-rate lever — the tool for a creeping resting HR (the RHR↑ marker): by slowing the heart and easing afterload it lowers BP and reduces the heart’s workload and wall stress, which is cardioprotective and helps prevent or regress left ventricular hypertrophy — the same remodeling androgens drive (a different route to the LVH protection telmisartan offers structurally). Reach for it when resting heart rate, not just blood pressure, needs reining in.
  • Amlodipine (calcium-channel blocker) — relaxes arterial walls for potent raw BP reduction, useful when an ARB alone isn’t enough. But it brings none of the kidney or metabolic benefits of an ARB, and its signature side effect is ankle/peripheral edema — vasodilatory swelling that can masquerade as steroid water retention. A blunt-force option, not a first pick for the enhanced athlete.
  • Indapamide (thiazide-like diuretic) — dumps sodium and water to shrink blood volume. It’s a heavy-hitter for genuinely dangerous blood pressure, not a “get drier” tool (see the warning below). Gentler than a loop diuretic, but it still pulls systemic water — it cannot target only the fluid under your skin — so it flattens muscles and crashes electrolytes when misused.

How to choose. ARB + tadalafil is the standard, complementary BP duo; add nebivolol when resting heart rate (not just BP) is elevated. ==If that combination already holds your BP in range, you do not add a diuretic.== Indapamide is reserved for blood pressure dangerous enough that the stroke/heart-attack risk outweighs the kidney strain it causes — and on harsh compounds a physician would likely lower your steroid dose and watch creatinine/eGFR before deploying it.

Why a diuretic is the wrong tool for "bloat"

Micro-dosing indapamide to look drier on a bulk is a dangerous misread of how the drug works:[^6]

  • It doesn’t protect the kidneys — it strains them. It works by dropping blood volume, and the kidneys need volume and pressure to filter. On Anavar, dumping volume can sharply drop your eGFR — acute kidney strain, the opposite of protection.
  • It can’t target subcutaneous water. It’s systemic, so it pulls water out of your blood and muscle cells too — flat muscles, dead pumps, worse performance.
  • It thickens your blood. Removing plasma while Boldenone/EQ is already driving hematocrit up makes the blood more sludge-like — which can raise BP and heart rate, not lower them.
  • It crashes potassium → cramps, weakness, arrhythmia — especially risky when you’re already manipulating potassium for carb fullness.

On a bulk, some fluid retention is the mandatory tax of a high-anabolic, high-glycogen state — every gram of glycogen drags 3–4 g of water into the muscle, and that water is fuel, not failure. Manage the look with foundational habits, not a diuretic: 4–5 L of water daily (consistent intake stops the body hoarding subcutaneous water), potassium without filling up (spinach, avocado, or potassium-citrate powder beat trying to eat six bananas), and 20–30 min of LISS cardio to sweat out sodium and keep vessels elastic. The real signal: if BP and heart rate keep climbing despite all that, the drug load is too heavy — lower the dose, don't mask it (the number is the boss).

Why nebivolol + tadalafil pair so well

They work the same nitric-oxide pathway from opposite ends: nebivolol is the factory (raising NO production) and tadalafil is the dam (blocking the breakdown of cGMP, NO’s downstream relaxation signal). Together at low doses they keep vessels relaxed and flexible — smooth BP and better pumps. With a low-dose ARB on top, the common framework is the lowest dose of each (e.g., 20 mg telmisartan / 2.5 mg nebivolol / 5 mg tadalafil), then track BP twice daily (waking and evening): aim for ~115/75–120/80, and don’t push below ~100/60 (dizziness, lethargy, flat workouts).

Glucose & insulin-sensitivity agents

GH (and insulin, if used) erode insulin sensitivity (Pathways 7 & 8); heavy eating compounds it. Five different tools, four different mechanisms:[^5]

AgentClass / mechanismBest useWatch-out
MetforminBiguanide; ↓ hepatic glucose, ↑ sensitivity, AMPKOff-season GH/insulin resistance; reliable first-lineGI upset (use extended-release)
Berberine (phytosome / cyclodextrin)Natural metformin-like (AMPK)OTC alternative to metforminPlain HCl has poor bioavailability — use enhanced forms
Saxagliptin (DPP-4 inhibitor)Prolongs incretins → glucose-dependent insulinMilder, food-responsive glucose controlWeaker than metformin for sensitisation / fat-burning; DPP-4 class heart-failure signal
Acarboseα-glucosidase inhibitor; blocks carb digestionReactively before high-carb / cheat mealsSignificant gas/bloat (“the gut tax”)
SGLT2 inhibitors (empagliflozin, dapagliflozin, ertugliflozin)Dump glucose in urine; ↓ BP & weight tooCutting — calorie dump + dry out; cardio-renal protectionEuglycemic DKA, genital infections, dehydration
TZDs (pioglitazone, lobeglitazone)Full PPAR-γ agonist; true insulin sensitisation + glycogen storage(mechanistically ideal for nutrient partitioning)==Avoid — severe fluid retention/bloat, masks conditioning, strains the heart’s preload==

How to choose. Metformin or berberine for ongoing GH-driven insulin resistance in a growth phase — but time metformin away from your training window (e.g., before bed): it activates AMPK, which suppresses mTORC1, so a big pre-workout dose can blunt the very muscle-protein-synthesis you’re training for. Saxagliptin is a gentler, food-responsive option that lacks metformin’s deep sensitising effect. Acarbose for the occasional big carb meal (if you’ll tolerate the bloat). SGLT2 inhibitor when cutting — calorie-dump + BP/water tool. Skip TZDs despite the seductive partitioning: the fluid retention is a nightmare on top of androgen water.

Retatrutide vs. metformin for insulin resistance

A glucagon triple agonist like retatrutide manages glucose centrally (appetite, gastric emptying, insulin secretion) rather than by forcing cellular energy stress — so it sidesteps metformin’s AMPK→mTOR muscle-blunting entirely. It’s far superior for cutting or deep insulin resistance, but its appetite crush and glucagon-driven glycogen/amino-acid turnover fight a high-calorie bulk. On a growth phase, low-dose metformin timed away from training is often easier to manage; on a cut, retatrutide wins.

Thyroid — T4 vs. T3

  • T4 (levothyroxine) — the inactive pro-hormone your body converts to T3. Its ancillary role is replacement/protection: high-dose GH accelerates T4→T3 conversion and can deplete background T4, so T4 keeps your metabolism stable on cycle. Dosed first thing AM, empty stomach, 30–60 min before food/caffeine.
  • T3 (liothyronine) — the active hormone, used aggressively for fat loss in a cut. More cardiac strain and muscle-wasting risk; demands FT3/FT4 tracking.

How to choose. T4 for on-cycle thyroid protection / GH support (the thyroid-triad fix). T4 + T3 only deep in a contest-prep fat-loss phase — which is squarely a Part 4.3 (bodybuilding realm) topic, not a protective one.

Organ & antioxidant support

Mostly complements, not competitors — but knowing which does what prevents redundancy:

  • TUDCA — treats cholestasis (bile backup) from oral 17-α-alkylated steroids. Run it only during oral runs (4–8 weeks); it can disturb normal lipid absorption when no orals are present.
  • NAC — glutathione precursor; cellular liver protection and broad antioxidant support. Year-round capable.
  • Injectable glutathione — the master antioxidant delivered directly (bypassing gut degradation); run in blocks during/after a heavy blast.
  • Astragalus root — herbal renal support (helps maintain eGFR) for heavier athletes; year-round.

How to choose. Orals in the stack → TUDCA for the duration. Baseline antioxidant/liver cover → NAC year-round, injectable glutathione in recovery blocks. Kidney-focused → astragalus. They stack rather than compete.

Prolactin & gyno (non-AI)

For managing prolactin and breast tissue without crushing systemic estrogen with an AI:

  • Prolactin (from 19-nors): P5P (vitamin B6) is the first-line, OTC control — effective and cheap (cap dosing to avoid B6 neuropathy). Cabergoline (dopamine agonist) is the reactive escalation when P5P fails and bloodwork shows prolactin spiking — potent, used ~twice weekly, physician-guided.
  • Gyno (estrogenic): Raloxifene is the modern gold standard for existing gyno — stronger affinity for breast tissue than tamoxifen, with fewer psychological side effects. Both block estrogen at the breast without lowering it systemically; tamoxifen also has a PCT role.

How to choose. On 19-nors → P5P prophylactically, cabergoline only reactively. Active gyno lump → raloxifene to reverse it; tamoxifen if raloxifene isn’t available or PCT is the goal.

Hair — 5-AR inhibitors vs. topicals

  • Finasteride (type-II 5-α-reductase inhibitor) — ~0.5–1 mg/day; lowers DHT. Caveat: only helps testosterone-derived hair loss — it does nothing against compounds that are already DHT-derivatives (Masteron, Primobolan, Winstrol, etc.).
  • Dutasteride (type I + II) — ~0.5 mg/day; more potent, for when finasteride fails. Same DHT-derivative limitation.
  • RU58841 / pyrilutamide — topical anti-androgens that block androgens at the scalp receptor, including direct DHT-derivatives that 5-AR inhibitors can’t touch. Research chemicals, no long-term human safety data — flagged for transparency, not endorsement.

How to choose. Test-based shedding → finasteride (→ dutasteride if it fails), accepting the systemic side-effect risk. Running DHT-derivatives, or want a non-systemic approach → topical RU58841/pyrilutamide, eyes open about the research-chemical status. And per Part 4.0: your first hair defense is compound selection, not a drug.

Oral minoxidil rewrites your BP stack

Oral minoxidil (used for hair preservation) lowers blood pressure by a different mechanism — it opens ATP-sensitive potassium channels (K_ATP) for aggressive vasodilation.[^7] The catch: that triggers a reflex RAAS response (sodium/water retention) and reflex tachycardia — and stacked on Test/Anavar water it can cause serious fluid overload, even pericardial effusion. ==If you run oral minoxidil, an ARB (to block the RAAS water retention) and nebivolol (to blunt the reflex tachycardia) stop being optional and become non-negotiable.==

Receptor & recovery support

  • Injectable L-Carnitine — its standout ancillary role is upregulating androgen-receptor density (Pathway 1), letting you get more from a given androgen dose, plus fat-metabolism support. Injectable is preferred — oral converts to TMAO (cardiovascular-unfriendly) and absorbs poorly.
  • Trazodone — a low-dose (25–50 mg) non-addictive sleep aid that deepens slow-wave sleep, indirectly supporting recovery and tissue repair — the boring-but-real foundation from Part 1.1.

Neuroprotection — defending the brain

Family job: protecting mood, cognition, and the brain’s vasculature from the neurological stress of heavy androgens. The brain is the quietest casualty of an aggressive protocol — supraphysiological androgens (trenbolone especially) are linked to neuroinflammation, anxiety, insomnia, and the mood/aggression shifts Part 4.0 flagged; crashed estradiol strips out a major neuroprotective signal; and chronic high blood pressure quietly damages the brain’s small vessels. The defense is mostly lifestyle, partly supplemental.[^8]

The non-negotiable levers come first — they outweigh any capsule:

  • Keep estradiol in range. Estrogen — not testosterone — is the neuroprotective sex hormone, so crashing E2 with an AI (Pathway 3) costs you mood, cognition, and brain protection. One more reason to manage, don’t crush.
  • Sleep — the deep-sleep / trazodone foundation is the single biggest neuro and mood lever there is.
  • Control blood pressure — defending the brain’s vasculature from stroke and small-vessel damage is the same BP work above.
  • Limit trenbolone — the harshest neuro-offender (“tren brain”: anxiety, insomnia, aggression). Short, specific windows only (Part 3.0).

The supplement layer (best-supported first):

  • Omega-3 (EPA/DHA), 2–4 g/day — anti-neuroinflammatory and mood-supportive; the same dose already protecting your lipids does double duty here.
  • Creatine, 5 g/day — beyond muscle, it buffers brain energy with genuine evidence for cognition and mood, especially under sleep deprivation.
  • NAC, 1–2 g/day — your liver antioxidant

Graph View

Backlinks